Description of results of SD-TOPSIS application (combination A) using selected moment characteristics. by Roman Vavrek (13200141)

Subjects:

Results of SD-TOPSIS application ‐ combinations B1-B5. by Roman Vavrek (13200141)

Subjects:

Results of SD-TOPSIS application ‐ combinations C1-C10. by Roman Vavrek (13200141)

Subjects:

A set of 2 criteria for the needs of multi-criteria evaluation ‐ combinations D1–D10. by Roman Vavrek (13200141)

Subjects:

The importance of entry criteria from the point of view of the SD method ‐ combinations C1 –C10. by Roman Vavrek (13200141)

Subjects:

The importance of entry criteria from the point of view of the SD method ‐ combination A. by Roman Vavrek (13200141)

Subjects:

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”

Dual-species biofilms of <i>S</i>. <i>mutans</i> and <i>C</i>. <i>albicans</i> on the dentin surface after pH cycling study showing sparse biofilm development on SDF exposed dentin... by Suphanida Kaewkamchai (19762172)

Subjects:

Mean lesion depth of the SDF test groups and the SDF-free group at baseline and post-cycling time points. by Suphanida Kaewkamchai (19762172)

Subjects:

Mean mineral density of the SDF test groups and the SDF-free group at baseline and post-cycling time points. by Suphanida Kaewkamchai (19762172)

Subjects:

Representative SEM images of the dentin surface topography of the three SDF test groups and the SDF-free group. by Suphanida Kaewkamchai (19762172)

Subjects:

Typical X-ray diffraction patterns of the dentin of the three SDF treated groups and the control group. by Suphanida Kaewkamchai (19762172)

Subjects:

The schematic illustration of the experimental process. by Suphanida Kaewkamchai (19762172)

Subjects:

The viability of <i>S</i>. <i>mutans</i> and <i>C</i>. <i>albicans</i> (log CFU/ml) and the wet weight of dual-species biofilms (mg) of the experimental and the control groups afte... by Suphanida Kaewkamchai (19762172)

Subjects:

Supplementary data: Flowchart of the study. by Suphanida Kaewkamchai (19762172)

Subjects:

Table_1_FMT intervention decreases urine 5-HIAA levels: a randomized double-blind controlled study.DOCX by Lihong Wang (14991)

“…However, in the placebo group, GSRS, CARS, and SRS scores showed no significant changes, while ABC scores decreased from 72 to 58.75 (p = 0.034). …”

Changes in the monthly contamination rate (per set) in blood culture (BC). by Miki Doi (15347878)

Subjects:

Patient background and blood culture-related factors before and after revision of the blood culture collection protocol. by Miki Doi (15347878)

Subjects: